Catalyst Wire Dossier Catalyst Wire Dossier

Epetraborole

epetraborole · AN2 Therapeutics, Inc
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Epetraborole, covering 2025-05-08 to 2026-06-10. Get the full timeline:

Most recent: Clinical Trial Results: Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease [Phase 2, Phase 3]

See pricing